Neurogenic bladder (NB) post‐meningomyelocele (MMC) repair is a major challenge and needs lifelong follow‐up. Many cytokines have been implicated in the pathogenesis of NB. To avoid repeated urodynamic studies (UDS)… Click to show full abstract
Neurogenic bladder (NB) post‐meningomyelocele (MMC) repair is a major challenge and needs lifelong follow‐up. Many cytokines have been implicated in the pathogenesis of NB. To avoid repeated urodynamic studies (UDS) and renal scans, we studied urinary tissue inhibitors of metalloproteinases‐2 (TIMP‐2) levels and correlated with urodynamic profiles to establish their efficacy.
               
Click one of the above tabs to view related content.